Enhance Skin Products Inc. (fka EHSK)

[Mean Weimaraner]

$EHSK management look - chief scientific officer started his career at johnson and johnson 50 years ago

Donald Nicholson CEO,Director:

-former CFO of SkyePharma PLC $400m mk cap http://www.skyepharma.com/

-currently founding shareholder & CEO of Mercuriali Ltd., a development stage United Kingdom private healthcare company.

Sam Asculai chairman, chief scientific officer:

Dr. Asculai held senior positions with Verigen AG, ens Bio-Logicals ; Monsanto Corporation, and the Ortho Pharmaceutical Corporation division of Johnson & Johnson.


From April 1998 to January 2003, Dr. Asculai served as the Chief Executive Officer of Verigen AG.
From January 1982 to September 1987, Dr. Asculai served as Vice President--Operations of ens Bio-Logicals.
From 1975 to 1982, Dr. Asculai served as Manager, Research and Development at Monsanto Corporation. From 1965 to 1975, Dr. Asculai held various positions in the Ortho Pharmaceutical Corporation division of Johnson & Johnson.